More than 96% of Claimants Opt-In to ACTOS Resolution Program

Daniels Tredennick Pharmaceutical and Mass Torts Leave a Comment

FiercePharma is reporting that Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. (collectively “Takeda”), today announced that more than 96 percent of eligible claimants have opted into the ACTOS (pioglitazone HCl) product liability resolution program that was announced on April 28, 2015. Takeda now is evaluating the submissions to determine whether they satisfy various criteria specified under terms …

Takeda Offers Even More to Settle Actos: Total Settlement Reaches Even Greater Heights

Daniels Tredennick Pharmaceutical and Mass Torts Leave a Comment

Bloomberg is reporting today that Takeda is now offering $2.3 billion – $100 million more than was offered on April 1, 2015 – to settle the 8,000 Actos cases currently on file in state and federal courts across the U.S. This is equal to $287,500 per case which figures to be only $12,500 more per case than their previous offer. …

ACTOS UPDATE: Takeda Offers Massive Settlement for Actos Users

Daniels Tredennick Pharmaceutical and Mass Torts Leave a Comment

Bloomberg News is reporting that Takeda Pharmaceutical Co., Asia’s largest drugmaker, is offering a $2.2 billion settlement for the 8,000 Actos lawsuits filed in state and federal courts throughout the U.S. On an individual basis, the settlement amount figures to be $275,000 per lawsuit. As the T&T blog has reported in the past, Actos sales peaked in March 2011 at …

Takeda Told to Pay Punitive Damages in Actos Claims

Daniels Tredennick Pharmaceutical and Mass Torts Leave a Comment

A jury ordered Takeda Pharmaceutical Co. to pay $1.3 million in punitive damages to a former teacher who argued the drugmaker’s Actos diabetes medicine caused his bladder cancer, in the company’s fifth loss in trials over the drug. Jurors in state court in Philadelphia deliberated more than two hours Friday before concluding that Osaka, Japan-based Takeda must pay the punitive …

Takeda Jury in Philadelphia Told Actos Responsible for Man’s Cancer

Daniels Tredennick Pharmaceutical and Mass Torts Leave a Comment

A Philadelphia jury was sent to deliberate Wednesday afternoon after being urged to find that Takeda Pharmaceuticals Inc. had willfully worked to obscure evidence linking the blockbuster diabetes drug Actos to an increased risk of bladder cancer. Miller Firm LLC attorney Michael Miller asked the jury during closing arguments to return a verdict in favor of plaintiff John Kristufek, who …

Pa. Judge Won’t Strike Actos Verdict Against Takeda

Daniels Tredennick Pharmaceutical and Mass Torts Leave a Comment

Pennsylvania judge has declined to overturn a $2 million verdict awarded in October to a plaintiff who claimed that the Takeda Pharmaceuticals Inc. drug Actos was a significant contributor to her developing bladder cancer. In an order docketed on Friday, Philadelphia Court of Common Pleas Judge Shelly Robins New rejected the company’s post-trial motions, in which they had argued that …

Actos Caused Consumer’s Bladder Cancer, Philly Jury Hears

Daniels Tredennick Pharmaceutical and Mass Torts Leave a Comment

A Philadelphia jury heard opening arguments on Wednesday in a case against Takeda Pharmaceutical Co., the latest in a string of suits against the drugmaker, alleging that a retired high-school teacher developed bladder cancer after taking the diabetes drug Actos. Miller Firm LLC attorney Michael Miller told the jury that warnings issued beginning in June 2011 about the risks associated …

Eli Lilly, Takeda Win Dismissal Of Ark. Taxpayer Actos Suit

Daniels Tredennick Pharmaceutical and Mass Torts Leave a Comment

A Louisiana federal judge on Thursday threw out a proposed class action alleging that Takeda Pharmaceutical Co. and Eli Lilly & Co. ripped off taxpayers by hiding the risks of their diabetes drug Actos, after the Arkansas Supreme Court ruled the drug was properly prescribed by doctors. In a two-page order granting the defendant’s motion to dismiss for failure to …

Takeda Ordered to Pay for Destroying Actos Files

Daniels Tredennick Pharmaceutical and Mass Torts Leave a Comment

Bloomberg is reporting that Takeda Pharmaceutical was ordered by a jury to pay $155,000 over its destruction of documents about its Actos diabetes medicine after the panel concluded the missing files blocked a man from proving his claims that the drug caused his cancer. Jurors in state court in Martinsburg, West Virginia, deliberated about three hours today before concluding Takeda …

Actos Update: Takeda Lowers Punitive Damages Penalty

Daniels Tredennick Pharmaceutical and Mass Torts Leave a Comment

Takeda Pharmaceutical Co. and Eli Lilly & Co. won a more than a 99 percent cut in a $9 billion punitive damages award over claims the drugmakers hid the cancer risks of their Actos diabetes medicine. Jurors properly found officials of Osaka, Japan-based Takeda and Indianapolis-based Lilly intentionally hid the health risks of the drug and should pay punitive damages, …